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Abstract Here, using mouse squamous cell carcinoma cells, we report a completely new
function for the autophagy protein Ambra1 as the first described ‘spatial rheostat’ controlling the
Src/FAK pathway. Ambra1 regulates the targeting of active phospho-Src away from focal adhesions
into autophagic structures that cancer cells use to survive adhesion stress. Ambra1 binds to both
FAK and Src in cancer cells. When FAK is present, Ambra1 is recruited to focal adhesions,
promoting FAK-regulated cancer cell direction-sensing and invasion. However, when Ambra1
cannot bind to FAK, abnormally high levels of phospho-Src and phospho-FAK accumulate at focal
adhesions, positively regulating adhesion and invasive migration. Spatial control of active Src
requires the trafficking proteins Dynactin one and IFITM3, which we identified as Ambra1 binding
partners by interaction proteomics. We conclude that Ambra1 is a core component of an
intracellular trafficking network linked to tight spatial control of active Src and FAK levels, and so
crucially regulates their cancer-associated biological outputs.
DOI: 10.7554/eLife.23172.001
Introduction
Ambra1 (activating molecule in Beclin1-regulated autophagy) is a WD40 domain-containing protein
that is involved in the development of the central nervous system, adult neurogenesis and vertebrate
embryogenesis (Benato et al., 2013; Fimia et al., 2007; Yazdankhah et al., 2014). It is an autoph-
agy regulator, binding to Beclin1 and playing a role in the initiation of autophagy, which is required
for neurogenesis (Fimia et al., 2007). When autophagy is not initiated, the Ambra1-Beclin1-Vps34
complex is bound to the dynein motor complex. Upon induction of autophagy, Ambra1 gets phos-
phorylated by the kinase ULK1, resulting in its release from the dynein complex (Di Bartolomeo
et al., 2010; Strappazzon et al., 2011). Ambra1 function is negatively regulated by mTOR phos-
phorylation, which suppresses its binding to the E3-ligase TRAF6 and ULK1 ubiquitylation, thus
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controlling ULK1 stability and function (Nazio et al., 2013). During apoptosis, Ambra1 expression is
regulated by caspase-mediated cleavage as well as degradation by calpains (Pagliarini et al., 2012),
and a recent study reported the ubiquitylation and subsequent degradation of Ambra1 by RNF2
(Xia et al., 2014). Further, Ambra1 has been reported to support the binding of c-Myc to the phos-
phatase PP2A, leading ultimately to c-Myc degradation and reduced cell proliferation and tumouri-
genesis (Cianfanelli et al., 2015), whilst a different study implied that Ambra1 overexpression in
cholangiocarcinoma has been correlated with invasion and poor survival (Nitta et al., 2014).
In the present study, we found that Ambra1 is a focal adhesion kinase (FAK)- and Src-binding
partner. We therefore investigated the role of Ambra1 in tumour-associated phenotypes regulated
by the Src/FAK pathway in squamous cell carcinoma (SCC) cells derived from the DMBA/TPA model
of carcinogenesis (driven by mutated oncogenic H-Ras) (Quintanilla et al., 1986). We have previ-
ously shown that FAK-dependent phenotypes include cancer cell polarisation and directional migra-
tion, depending primarily on FAK’s protein scaffolding activities, including binding to actin
regulators like Eps8, Arp3 and RACK1 (Schoenherr et al., 2014; Serrels et al., 2010, 2007). In par-
ticular, genetic depletion of FAK, or detachment of FAK-expressing cells, cause active Src to be traf-
ficked from focal adhesions at the cell periphery to intracellular puncta containing autophagy
proteins. We termed this ‘adhesion-stress-induced autophagy’, and it is FAK and adhesion depen-
dent rather than nutrient dependent, in contrast to the classical, starvation-induced autophagy. It
provides a novel mechanism for coping with high levels of active Src, and other oncogenic kinases
like Ret, which are not spatially controlled in the usual way by their binding to FAK
(Sandilands et al., 2012a, 2012b).
We found that Ambra1 is critically involved in Src/FAK-dependent cancer cell polarisation and
chemotactic invasion. In FAK-depleted SCC cells, Ambra1 controls the targeting of active Src to
intracellular autophagic puncta. This is mediated by the novel Ambra1-binding proteins Dynactin 1
(Dctn1; also known as p150Glued) and interferon-induced transmembrane protein 3 (IFITM3), which
together with Ambra1, are critical to trafficking processes that control spatial Src activity and Src-
dependent phenotypes. A FAK mutant that is not able to bind Ambra1 promotes increased cell
eLife digest In animal bodies, a mesh of proteins – known the extracellular matrix – holds cells
together to give the body shape and make it more stable. Cells bind to the matrix using structures
called focal adhesions. However, cells do not always stay in one place: in young animals, certain cells
need to move around the body to reach their final destination. Adult animals also have some cells
that are able to move, for example, to close wounds. The cells move when the focal adhesions that
hold these cells in place are taken apart and then rebuilt. These processes are very dynamic and
happen all the time when cells move. They are normally tightly controlled to ensure that cells only
migrate under appropriate conditions. However, focal adhesions are less well regulated in cancer
cells, allowing the cells to migrate away from a tumour to form new tumours elsewhere in the body.
Focal adhesions are large structures that contain many proteins. These proteins include FAK and
Src, which are particularly important and have been well studied. In order to better understand how
focal adhesions are taken apart, Schoenherr et al. wanted to discover new proteins that interact with
FAK in skin cancer cells from mice. The experiments show that FAK binds to a protein called
Ambra1, which is known to control how other proteins move around inside cells. Ambra1 and FAK
work together to regulate the movement of Src away from focal adhesions and into the cell.
Furthermore, Ambra1 belongs to a larger network of proteins within the cancer cells that regulates
the location of Src. By changing the levels of Src and FAK at focal adhesions, Ambra1 and its other
binding partners can control whether the cancer cells are attached to the extracellular matrix or are
free to migrate.
Overall this work shows that the location and activity of Src within cells needs to be carefully
controlled to stop the cells from moving at the wrong time. Further experiments will aim to
understand which other proteins are involved in this network and how they contribute to the growth
of cancer cells and the spread of tumours around the body.
DOI: 10.7554/eLife.23172.002
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adhesion and invasion by retaining more phospho-FAK (pFAK) and phospho-Src (pSrc) at focal adhe-
sions – showing that Ambra1 can both positively and negatively regulate the amount of active Src at
cellular adhesion sites. Overall, these data imply a novel role for the autophagic protein Ambra1,
and its key interacting partners Dynactin 1 and IFITM3, at the heart of an intracellular trafficking net-
work that, in turn, acts as a ‘spatial rheostat’ for phospho-Src and Src/FAK-mediated cancer
processes.
Results
Ambra1 interacts with FAK in SCCs and localises at focal adhesions
We discovered Ambra1 in a phage display screen for novel FAK binding partners. As Ambra1 regu-
lates autophagy, and we had already published that active Src was trafficked away from adhesions
via autophagosomes in the absence of FAK (Sandilands et al., 2012a), we set out to test the
involvement of Ambra1 in the autophagic trafficking of active Src. First, we confirmed Ambra1 as a
novel FAK binding partner in SCC cells by reciprocal co-immunoprecipitations (co-IPs; Figure 1A,B).
The IPs were validated using FAK-deficient (-/-) SCC cells and Ambra1 -/- mouse embryonic fibro-
blasts (MEFs) (Figure 1C; Figure 1—figure supplement 1A,B). In order to confirm the co-localisa-
tion between FAK and Ambra1, we performed immunofluorescence (IF). In both SCC FAK-WT and
FAK -/- cells, Ambra1 displayed diffuse cytoplasmic localisation with some at focal adhesions
(Figure 1D). Therefore, we isolated focal adhesions from FAK-WT and FAK -/- cells by hydrodynamic
force and found that Ambra1 co-localised with FAK and Paxillin at isolated focal adhesions
(Figure 1E; Figure 1—figure supplement 1C–E). Additionally, Ambra1 localised to hydrodynamic
force-isolated nascent focal adhesions, marked by the presence of RACK1 (de Hoog et al., 2004;
Serrels et al., 2010, 2007), in both FAK-WT and FAK -/- cells (Figure 1F). However, the non-autoph-
agy, non-adhesion cellular protein CoxIV was not found at isolated focal adhesions, implying that
the IF staining was not of general cellular debris (Figure 1—figure supplement 1D,E). In addition,
we found that Ambra1 was present at focal adhesions at the cell-surface interface by Total Internal
Reflection Fluorescence (TIRF) microscopy; there was partial overlap with pSrc Y416 and FAK, sug-
gesting that, as with other autophagy proteins we have reported previously (Sandilands et al.,
2012a; Schoenherr et al., 2014), there are pools of Ambra1 discretely present at sub-locations
within focal adhesions (Figure 1—figure supplement 1F,G; Figure 5—figure supplement 2C,D).
Ambra1 binds to Src and is required for trafficking of active Src to
autophagosomes
We previously showed that active Src is localised to intracellular puncta containing autophagy pro-
teins in FAK -/- SCC cells, allowing FAK-deficient cancer cells to cope with high levels of ‘untethered’
active Src (and other FAK-interacting tyrosine kinases, e.g. Ret) (Sandilands et al., 2012a,
2012b). Other FAK- and Src-interacting proteins, like the actin regulator Eps8, are also involved in
this spatial localisation of active Src (Schoenherr et al., 2014). Since Ambra1 is a recognised autoph-
agy regulator, we addressed whether it was required for the trafficking of Src to autophagosomes in
FAK-deficient cells. Ambra1 and Src, including active phospho-Src (pSrc; pY416), formed a biochemi-
cal complex both in FAK-expressing and -deficient SCC cells as shown by co-immunoprecipitation
(Figure 2A,B). Using immunofluorescence, we found that Ambra1 localised to intracellular puncta
that contain autophagy-regulating proteins like LC3B (Figure 2C,D). We noted that Ambra1 also
appeared to localise to nuclei, and although we confirmed this by probing nuclear proteins isolated
after cell fractionation and sucrose gradient purification of nuclei, we do not know its significance
(Figure 2—figure supplement 1A,B). In FAK-deficient SCC cells, Ambra1 co-localised with pSrc,
indicating that active Src and Ambra1 localised to the same intracellular puncta, described previously
to contain autophagy proteins (Figure 2C). The localisation of Ambra1 in these autophagosomes
was consistent with co-immunoprecipitation with LC3B, providing evidence that they were present in
the same biochemical complex (Figure 2E). We note that there was a reduced steady state level of
the lipidated form of LC3B (LC3B II) in the SCC FAK -/- cells (the significance of this is unknown;
[Sandilands et al., 2012a]). We are not able to discern which isoform of LC3B is binding to Ambra1
or whether there is any difference between them.
Schoenherr et al. eLife 2017;6:e23172. DOI: 10.7554/eLife.23172 3 of 22
Research article Cancer Biology Cell Biology
Figure 1. Ambra1 interacts with FAK at focal adhesions. FAK or Ambra1 were immunoprecipitated from FAK-WT
and FAK -/- cell lysates using (A) anti-FAK 4.47 agarose or (B) anti-Ambra1, followed by western blot analysis with
anti-FAK and anti-Ambra1. (C) FAK was immunoprecipitated from Ambra1 +/+ and Ambra1 -/- MEF cell lysates
using anti-FAK 4.47 agarose, followed by western blot analysis with anti-FAK and anti-Ambra1. Anti-b-actin was
used as a loading control. Relative ratios of Ambra1, FAK/Ambra1 and Ambra1/FAK interactions were calculated
by densitometry. (D) FAK-WT and FAK -/- cells were seeded onto glass coverslips, fixed and stained using anti-
Ambra1 and anti-Paxillin. Scale bars, 20 mm. (E, F) Focal adhesions were isolated from FAK-WT and FAK -/- cells
using hydrodynamic force. (E) Focal adhesions (solid arrows) were stained with anti-FAK and anti-Ambra1 (left
panels) and with anti-Ambra1 and anti-Paxillin (right panels). (F) Focal adhesions (solid arrows) were stained with
anti-Ambra1 and anti-Rack1 in SCC FAK-WT (left panels) and SCC FAK -/- cells (right panels). Scale bars, 20 mm.
Colocalisation (Costes r value from five cells) was analysed using the ImageJ plugin JaCoP (Bolte and
Cordelie`res, 2006).
DOI: 10.7554/eLife.23172.003
The following source data and figure supplements are available for figure 1:
Source data 1. COSTES r values for immunofluorescence images.
DOI: 10.7554/eLife.23172.004
Figure supplement 1. Ambra1 +/+ and -/- mouse embryonic fibroblasts (MEFs).
DOI: 10.7554/eLife.23172.005
Figure 1 continued on next page
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To investigate whether Ambra1 controlled active Src localisation, we suppressed expression of
Ambra1 with both a pool of four and two individual siRNAs (Figure 2F). Knockdown of endogenous
Ambra1 either by the pool of four siRNAs (Figure 2G,H) or two individual siRNAs (Figure 2I,J)
resulted in the redistribution of active Src from intracellular puncta back to focal adhesions in FAK -/-
cells. However, we were unable to determine whether this relocation would also occur in detached
cells, which do not have focal adhesions. Taken together, these data imply that Ambra1 is required
for the trafficking of active Src from focal adhesions to intracellular autophagic puncta.
Ambra1 is part of a network of trafficking proteins linked to active Src
and FAK
We next performed Ambra1, pSrc Y416, and FAK (and IgG control) IPs using lysates from FAK-WT
and FAK -/- cells (in triplicate) and determined specifically interacting proteins by quantitative label-
free mass spectrometry. Amongst the binding partners of all three ‘baits’ were proteins that are
involved in regulating intracellular trafficking, raising the possibility that Ambra1 is part of a Src/FAK
‘trafficking network’ (Figure 3A; Supplementary file 1–3).
To test the hypothesis that Ambra1-dependent targeting of pSrc from focal adhesions to intracel-
lular autophagic puncta involved such trafficking proteins, we selected two novel Ambra1 binding
partners for further study. These were Dynactin 1, whose interaction with Ambra1 appeared to be
enriched in FAK-deficient cells from proteomics analyses (Figure 3) and IFITM3, which was posi-
tioned at the centre of the trafficking network as it bound to all three of Ambra1, pSrc and FAK (Fig-
ure 3). Dctn1 (Dynactin 1) is a component of the dynactin complex and is involved in dynein-
mediated transport along microtubules, enhancing motor processivity (Culver-Hanlon et al., 2006;
King and Schroer, 2000; Waterman-Storer et al., 1995), and mediating trafficking and maturation
of EGFR and lysosomes (Kedashiro et al., 2015b; Li et al., 2014). We confirmed the interaction
between Ambra1 and Dynactin 1 by co-IP, thereby validating the interaction identified by mass spec-
trometry (Figure 3B). IFITM3, which forms a central node linking the Ambra1, pSrc and FAK traffick-
ing networks (Figure 3A), is known to block cellular entry of viruses (Amini-Bavil-Olyaee et al.,
2013; Brass et al., 2009; Feeley et al., 2011; Huang et al., 2011; Lu et al., 2011; Weidner et al.,
2010), to traffic with Rab7 and LAMP1, and to interact with v-ATPase on endosomes to enable cla-
thrin localisation (Feeley et al., 2011; Wee et al., 2012). IFITM3 is highly expressed in many cancers
(Andreu et al., 2006; Hu et al., 2014; Li et al., 2011; Yang et al., 2013) and has been variously
implicated in tumour cell proliferation, migration and invasion (Hu et al., 2014; Li et al., 2011;
Yang et al., 2013; Zhao et al., 2013). We confirmed the interaction between Ambra1 and IFITM3
(Figure 3C), FAK and IFITM3 (Figure 3D), and pSrc and IFITM3 (Figure 3E) by co-IPs. The interac-
tions between IFITM3 and both Ambra1 and pSrc appeared to be enriched in FAK-expressing cells
due to increased IFITM3 expression levels, caused by FAK-dependent IFITM3 transcription (not
shown; (Figure 3A), and we believe that IFITM3 is present at focal adhesions, shown by immunoblot-
ting of isolated focal adhesion preparations (Figure 3—figure supplement 1A).
To determine whether IFITM3 was required for complex formation between active Src and
Ambra1 in FAK-WT and -/- cells, we knocked down IFITM3 using a pool of siRNAs and analysed the
interaction of Ambra1 and pSrc by co-immunoprecipitations (Figure 3—figure supplement 1B,C).
While knockdown of IFITM3 did not affect the Ambra1-pSrc interaction (Figure 3—figure supple-
ment 1B,C), IFITM3 depletion reduced the interaction between FAK and active pSrc, indicating that
IFITM3 is involved in the optimal association of Src to FAK (Figure 3—figure supplement 1D,E),
likely through regulating their precise localisation. Thus, interaction network analysis coupled with
co-immunoprecipitations suggest that IFITM3 is a central component of a trafficking network linking
Ambra1, FAK and active Src (Figure 3A).
Figure 1 continued
Figure supplement 2. Knockdown of Ambra1 suppresses FAK phenotypes.
DOI: 10.7554/eLife.23172.006
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Figure 2. Ambra1 interacts with Src and mediates trafficking of active Src to autophagosomes. (A, B) Src (A) or pSrc Y416 (B) were immunoprecipitated
from FAK-WT and FAK -/- cell lysates using anti-Src agarose or anti-pSrc Y416 antibody, followed by western blot analysis with anti-Ambra1, anti-pSrc
Y416 and anti-Src. Relative ratios of Ambra1/Src and Ambra1/pSrc interactions were calculated by densitometry. (C) FAK-WT and FAK -/- cells were
seeded onto glass coverslips, fixed and stained using anti-pSrc Y416, anti-Ambra1 and DAPI. Scale bars, 20 mm. (D) SCC FAK-WT and FAK -/- cells were
Figure 2 continued on next page
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Dynactin 1 and IFITM3 are involved in the trafficking of pSrc to
autophagosomes
Having verified that both Dynactin 1 and IFITM3 bind to Ambra1, we next addressed whether they
were involved in the Ambra1-dependent intracellular trafficking of active pSrc. We transiently
knocked down endogenous Dynactin 1 (Figure 4A) or IFITM3 (Figure 4D) by siRNA, and analysed
the localisation of active pSrc in FAK-deficient SCC cells. In both cases, suppression of protein
expression resulted in significant redistribution of active pSrc from intracellular autophagic puncta to
focal adhesions (Figure 4B,C; Figure 4—figure supplement 1A and Figure 4E,F; Figure 4—figure
supplement 1B respectively), while in FAK-expressing cells, knockdown of Dynactin 1 or IFITM3 had
no visible effect on their distribution. These data imply that Ambra1 is part of a functional trafficking
network that precisely regulates the spatial distribution of Src activity. Mechanistically, Ambra1 func-
tions via interaction with proteins involved in intracellular trafficking, including Dynactin 1 and
IFITM3; the latter lies at the centre of linked Ambra1, pSrc, and FAK interactomes.
Ambra1 is required for Src/FAK-mediated cancer-related processes
Having established that Ambra1 and FAK interact with each other and co-localise at focal adhesions
(Figure 1), and that they are co-determinants of the intracellular localisation of Src activity, we next
addressed whether Ambra1 was required for Src/FAK-mediated cancer-related processes. We there-
fore knocked down Ambra1, and found that there was significant loss of polarisation towards a
monolayer wound in FAK-expressing SCC cells, as judged by the direction of the Golgi apparatus
(stained with GM130). This was in contrast to FAK-deficient cells, in which knockdown of Ambra1
had no further effect on the already suppressed polarisation of cells towards a wound (Figure 1—
figure supplement 2A,B). The role of Ambra1 in polarisation was confirmed using Ambra1 +/+ and
-/- MEFs (Figure 1—figure supplement 2C). In addition, we found that Ambra1 was required for
chemotactic invasion into growth factor-reduced Matrigel in FAK-expressing cells (Figure 1—figure
supplement 2D,E), whilst there was no effect in FAK-deficient cells, which, as we described previ-
ously, do not invade into Matrigel (Serrels et al., 2012). These results describe a previously unknown
role for Ambra1 in cancer cell polarisation and invasion that is Src/FAK dependent.
A FAK Ambra1-binding mutant increased adhesion and active Src at
adhesions
As Ambra1 binds FAK and is found at isolated focal adhesions, we next addressed whether FAK and
Ambra1 interact directly. The Ambra1 binding site in FAK was mapped by peptide array binding
analysis as described previously (Schoenherr et al., 2014; Serrels et al., 2007), which resulted in
identification of two amino acids in FAK that were required for optimal direct binding of Ambra1,
i.e. amino acids P875 and P881. These prolines (P) were mutated to alanines (A), and the resulting
FAK P875A/P881A (AA) mutant caused reduced binding of Ambra1 to FAK within cells (Figure 5A,
B). The interaction between FAK and p130Cas, which also binds FAK at a similar proline-rich region
but not the same combination of amino acids (P715, P718, P878 and P881; ref. [Harte et al., 1996]),
was more modestly affected by the P875A/P881A mutation (quantified in Figure 5C).
Figure 2 continued
grown on glass coverslips, fixed and stained with anti-Ambra1, anti-LC3B and DAPI. Scale bars, 20 mm. (E) LC3B was immunoprecipitated from SCC
FAK-WT and FAK -/- cell lysates using anti-LC3B, followed by western blot analysis with anti-Ambra1 and anti-LC3B. Relative ratios of LC3B II/LC3B I as
well as the Ambra1/LC3B and Ambra1/LC3B II interactions were calculated by densitometry. (F–J) SCC FAK-WT and FAK -/- cells were transiently
transfected with either a pool (F–H) or two individual siAmbra1 siRNAs (F, I, J). The cells were grown on glass coverslips, fixed and stained with anti-
pSrc Y416, anti-Paxillin and DAPI. (G, I) Representative immunofluorescence images. Scale bars, 20 mm. (H, J) Quantification of internalised active Src.
n = 3. Error bars, s.d. p<0.001. Colocalisation (Costes r value from five cells) was analysed using the ImageJ plugin JaCoP.
DOI: 10.7554/eLife.23172.007
The following source data and figure supplement are available for figure 2:
Source data 1. COSTES r values for immunofluorescence images and percentage of cells with internalised pSrc.
DOI: 10.7554/eLife.23172.008
Figure supplement 1. Ambra1 interacts with Src and mediates pSrc trafficking.
DOI: 10.7554/eLife.23172.009
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Figure 3. IFITM3 is in the centre of an Ambra1, FAK and pSrc trafficking network. (A) Network analysis of Ambra1-, FAK- and pSrc Y416-interacting
proteins that are involved in trafficking processes. Solid lines indicate protein-protein interactions identified in the mass spectrometry datasets used for
the interaction map. Dotted lines indicate Ambra1–FAK/pSrc interactions, which have been previously identified and verified by immunoprecipitation.
(B) Ambra1 was immunoprecipitated from FAK-WT and FAK -/- cell lysates using anti-Ambra1 antibody, followed by western blot analysis with anti-
Figure 3 continued on next page
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When culturing the cells expressing FAK that was impaired in Ambra1 binding, we noticed that
these FAK P875A/P881A cells seemed to display greater adherence than the FAK-WT cells. There-
fore, we performed adhesion assays on fibronectin-coated dishes (Figure 5D) or on plastic (Fig-
ure 5—figure supplement 1A). We found that after 20 and 60 min, FAK P875A/P881A and FAK -/-
cells attached to a higher degree than FAK-WT cells. Furthermore, in already adhered FAK P875A/
P881A cells (Figure 5E, middle panels), we found that there was more intense pSrc staining at focal
adhesions when compared to FAK-WT cells (Figure 5E, top panels) or FAK -/- cells, in which pSrc
was present at intracellular autophagic puncta (Figure 5E, lower panels). Quantification of the rela-
tive intensity of pSrc at focal adhesions (Figure 5F) and of pSrc in intracellular puncta (Figure 5—fig-
ure supplement 1B) is shown. While there was more intense staining of active pSrc at focal
adhesions in FAK P857A/P881A cells, there were no significant changes in the number or size of
focal adhesions (Figure 5—figure supplement 1C,D). The increased staining of pSrc (and pFAK
Y397; Figure 5—figure supplement 1E) in FAK P875A/P881A cells was confirmed by immunoblot-
ting isolated focal adhesion preparations (Figure 5G, right panels, red dots; quantified as phospho/
total Src (and phospho/total FAK) in Figure 5H), demonstrating that both active pSrc and pFAK
were elevated relative to total Src and FAK, respectively. This was true also of pPaxillin Y118
(Figure 5G, right panels), reflecting specific retention of phospho- and activated- focal adhesion
components at focal adhesions when FAK cannot bind to Ambra1. This implies that the FAK–
Ambra1 complex is crucial to orchestrate the selective removal of active focal adhesion components
from focal adhesions or to promote their turnover at these adhesion sites. The elevated levels of
active components retained at focal adhesions when the binding of FAK to Ambra1 is impaired may
contribute to the enhanced adhesion at early times after plating on extracellular matrix (Figure 5D).
Ambra1 binding-deficient FAK causes increased invasion and 3D
proliferation
To determine whether there were other biological consequences of the aberrant accumulation, or
retention, of active pSrc and pFAK at focal adhesions when FAK binding to Ambra1 was impaired,
we examined chemotactic invasion into growth factor-reduced Matrigel and proliferation in three-
dimensional (3D) culture. We found that elevated active pSrc and pFAK at focal adhesions in FAK
P875A/P881A cells was associated with enhanced invasive migration (Figure 6A,B) and increased
proliferation in 3D compared to FAK-WT cells (Figure 6C,D), without affecting the Src-FAK interac-
tion (Figure 5—figure supplement 2E). As we found the Ambra1 binding partners Dynactin 1 and
IFITM3 to regulate the trafficking of active Src in FAK-deficient SCC cells (Figure 4), we asked
whether they also influenced mis-regulation of active pSrc and pFAK levels at focal adhesions when
FAK can no longer bind to Ambra1. We therefore transiently knocked down endogenous Dynactin 1
or IFITM3 expression using siRNA, and we found that the ‘over-invasion’ of FAK P875A/P881A-
expressing cells was restored to similar, or lower, invasion levels than FAK-WT-expressing cells
(Figure 6E–G). Additionally, elevated active pSrc levels in the FAK P875A/P881A SCC cells were
restored to normal (wildtype) levels by knocking down Dynactin 1 (not shown). These results demon-
strate that Ambra1 binding to FAK is required for the maintenance of normal steady-state levels of
active pSrc and pFAK at focal adhesions. When this binding is perturbed so that pSrc and pFAK are
elevated, the resultant enhanced invasion requires the Ambra1-interacting trafficking proteins
Dynactin 1 and IFITM3, which are therefore crucial mediators of active Src trafficking.
Figure 3 continued
Dctn1 and anti-Ambra1. (C–E) Ambra1 (C), FAK (D) or pSrc Y416 (E) were immunoprecipitated from FAK-WT and -/- cell lysates, followed by western
blot analysis with anti-IFITM3, anti-Ambra1, anti-FAK and anti-pSrc Y416. Anti-GAPDH served as a loading control. Relative ratios of Dctn1/Ambra1,
IFITM3/Ambra1, IFITM3 and IFITM3/pSrc interactions were calculated by densitometry.
DOI: 10.7554/eLife.23172.010
The following figure supplement is available for figure 3:
Figure supplement 1. IFITM3 influences the Src-FAK complex.
DOI: 10.7554/eLife.23172.011
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Figure 4. Knockdown of Dynactin 1 and IFITM3 suppresses trafficking of active Src to autophagic puncta. (A) FAK-WT and FAK -/- cells were transiently
transfected with a pool of Dynactin 1 (Dctn1) siRNAs and lysed 48 hr post transfection. Dynactin 1 expression was determined by western blotting using
anti-Dctn1. Anti-GAPDH was used as a loading control. (B) SCC FAK-WT and FAK -/- cells transiently transfected with Dctn1 siRNA were grown on glass
coverslips, fixed and stained with anti-pSrc Y416, anti-Paxillin and DAPI. Scale bars, 20 mm. (C) Quantification of internalised active Src. n = 3. Error bars,
Figure 4 continued on next page
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Discussion
Ambra1 is involved in Src/FAK-mediated cancer phenotypes
Our results define Ambra1 as a crucial regulator of Src/FAK-mediated cancer phenotypes, acting as
a ‘spatial rheostat’ to maintain steady-state levels of active pSrc and pFAK at adhesions (see model
in Figure 7). When FAK is present, Ambra1 forms a complex with FAK and Src and plays a key a role
in Src/FAK-regulated cancer cell adhesion, polarisation and invasion (Figure 7A). In FAK-deficient
cells, Ambra1 controls the targeting of active Src away from focal adhesions into autophagic struc-
tures that the cells use to cope with toxic levels of active Src when it is not ‘tethered’ at adhesion
sites by FAK (Figure 7B; Sandilands et al., 2012a). When Ambra1 is unable to bind to FAK (as is the
case in FAK P875A/P881A-expressing cells), this causes over-retention (lack of removal or turnover)
of active Src (and FAK) from focal adhesions, promoting cell adhesion and enhanced invasive migra-
tion (Figure 7C). Ambra1 is therefore a novel spatial regulator of the active Src/FAK complex at sites
of cell-matrix adhesion, controlling downstream biological effects in cancer cells. It does this by scaf-
folding trafficking proteins, for example, Dynactin 1 and IFITM3, which themselves lie at the heart of
a network of scaffolding proteins that are needed for optimal trafficking of active Src (and FAK),
maintaining appropriate and tolerated levels.
Control of Src/FAK spatial activities is a novel Ambra1 function
Ambra1 is crucial for the development of the central nervous system, neurogenesis and embryogen-
esis (Benato et al., 2013; Fimia et al., 2007; Yazdankhah et al., 2014), and is an autophagy regula-
tor, via its interaction with Beclin1 (Fimia et al., 2007). The role of Ambra1 in cancer is less clear.
One study suggested that Ambra1 may have a tumour suppressor role, as it is involved in the degra-
dation of c-Myc induced by dephosphorylation by PP2A, resulting in reduced proliferation and
tumourigenesis (Cianfanelli et al., 2015). However, another study implied that Ambra1 may have
tumour-promoting functions, since Ambra1 overexpression correlated with invasion and poor sur-
vival in cholangiocarcinoma (Nitta et al., 2014). The new findings we present here show that
Ambra1 contributes to SCC cell behaviour by scaffolding both Src and FAK, and intracellular traffick-
ing proteins, controlling steady-state levels and spatial distribution of the activated forms of Src and
FAK at focal adhesions. In this context, therefore, Ambra1 is a scaffold protein that promotes cancer
cell phenotypes driven by the Src/FAK pathway, including cancer cell polarisation and chemotactic
invasion. This central trafficking scaffold function of Ambra1, and the discovery that it is a crucial
‘spatial rheostat’ for Src/FAK signalling, adds to the number of important physiological functions for
Ambra1, and defines a new level of regulation of the Src/FAK signalling axis. It is interesting to note
that while knockdown of Ambra1 caused reduced cancer cell polarisation towards the denuded area
of a wounded monolayer, and suppressed chemotactic invasive migration in FAK-expressing cancer
cells, there was no effect in FAK-deficient cells, which display intrinsically low polarisation and inva-
sion capacity. We conclude that Ambra1 is a FAK scaffold required for FAK-dependent cancer cell
phenotypes, most likely by controlling the localisation of active FAK, and its upstream regulator Src,
at focal adhesions.
Figure 4 continued
s.d. p<0.01. (D) FAK-WT and FAK -/- cells were transiently transfected with a pool of IFITM3 siRNAs and lysed 48 hr post transfection. IFITM3
expression was determined by western blotting using anti-IFITM3. Anti-GAPDH was used as a loading control. (E) SCC FAK-WT and FAK -/- cells
transiently transfected with IFITM3 siRNA were grown on glass coverslips, fixed and stained with anti-pSrc Y416, anti-Paxillin and DAPI. Scale bars, 20
mm. (F) Quantification of internalised active Src. n = 3. Error bars, s.d. p<0.01.
DOI: 10.7554/eLife.23172.012
The following source data and figure supplement are available for figure 4:
Source data 1. Percentage of cells with internalised pSrc.
DOI: 10.7554/eLife.23172.013
Figure supplement 1. Knockdown of Dynactin 1 and IFITM3 suppress pSrc trafficking to autophagic puncta.
DOI: 10.7554/eLife.23172.014
Schoenherr et al. eLife 2017;6:e23172. DOI: 10.7554/eLife.23172 11 of 22
Research article Cancer Biology Cell Biology
Figure 5. Ambra1 binding impaired FAK increases cell adhesion and pSrc at focal adhesions. (A, B) FAK (A) or Ambra1 (B) were immunoprecipitated
from FAK-WT, FAK P875A/P881A (AA) and FAK -/- cell lysates using anti-FAK 4.47 agarose or anti-Ambra1, followed by western blot analysis with anti-
FAK, anti-Ambra1 and anti-p130Cas. Anti-GAPDH was used as a loading control. (C) Relative ratios of Ambra1/FAK and p130Cas/FAK interactions were
calculated by densitometry. (D) Adhesion assay: SCC FAK-WT, FAK P875A/P881A and FAK -/- cells were plated in serum-free conditions on fibronectin-
Figure 5 continued on next page
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Ambra1 is at the centre of a trafficking network that spatially regulates
Src
Ambra1 is reported to be an autophagy regulator (Fimia et al., 2007), and we found that it is cru-
cially involved in the redistribution of active Src away from focal adhesions into intracellular autopha-
gic puncta in FAK-deficient cancer cells (described previously in Sandilands et al., 2012a). Ambra1
is localised to intracellular puncta containing the autophagosomal marker LC3B, and it interacts with
LC3B. These data implicate Ambra1 in the selective autophagic trafficking of active Src when cancer
cells are under severe ‘adhesion stress’, such as when FAK is absent.
We found that Ambra1-interacting proteins (identified by mass spectrometry) included the dynac-
tin complex component Dynactin 1 and IFITM3, in addition to other proteins considered to be intra-
cellular trafficking proteins. As Ambra1 has been reported to interact with the dynein complex, we
thought it likely that Ambra1 may regulate the trafficking of active Src to intracellular autophagic
puncta via dynein-dependent processes (Di Bartolomeo et al., 2010), and we found that knock-
down of endogenous Dynactin 1 by siRNA inhibited the trafficking of active Src from focal adhesions
to autophagosomes. Dynactin 1 is thought to be involved in retrograde trafficking and maturation of
trafficking vesicles (Jovasevic et al., 2015; Kedashiro et al., 2015a; Li et al., 2014;
Ohbayashi et al., 2012; Verissimo et al., 2015), implying that these may be involved in the redistri-
bution of active Src from focal adhesions to autophagosomal puncta in FAK-deficient cells. We
noted that Dynactin 1 knockdown resulted in enlarged late endosomes (not shown), while the num-
ber of late endosomes was not altered (not shown), implying that impaired trafficking/maturation of
vesicles may be responsible for the block to autophagic targeting of active Src upon Ambra1 and
Dynactin 1 knockdown. Further, IFITM3 has been reported to localise to late endosomes/lysosomes
and overexpression expands Rab7- and LAMP1-positive structures (Feeley et al., 2011), and loss of
IFITM3 blocks clathrin-mediated phagocytosis by removing clathrin from membranes (Wee et al.,
2012). Knockdown of IFITM3 also significantly impaired the trafficking of active Src to autophagic
puncta. In proteomic network analyses, we found that IFITM3 interacts both with FAK and active Src,
as well as Ambra1, thereby linking the Ambra1-, FAK- and pSrc-interacting trafficking protein net-
works together. Furthermore, IFITM3 appears to be important for the interaction of active pSrc with
FAK as well as to a lesser extent of Ambra1 with FAK (not shown), but not Ambra1 with pSrc. These
findings suggest that IFITM3 is involved in regulating FAK’s interaction with Ambra1 and pSrc. Over-
all, these data place IFITM3 at the centre of a larger trafficking protein network linking Ambra1, FAK
and active Src sub-networks. The full range of the Src/FAK/Ambra1-interacting trafficking proteins
from the interactome network (Figure 3) that play a role in pSrc trafficking are unknown at present.
Figure 5 continued
coated plates. Samples were normalised to the 6 hr time point and relative adhesion was calculated by setting the FAK-WT values to 1. n = 3. Error
bars, s.d. p0.01. (E, F) SCC FAK-WT, FAK P875A/P881A and FAK -/- cells were grown on glass coverslips for 24 hr, fixed and stained with anti-pSrc
Y416, anti-Paxillin and DAPI. Scale bars, 20 mm. The relative intensity of pSrc staining at focal adhesions from five cells (at least 10 focal adhesions/cell)
was measured using ImageJ. (E) Representative immunofluorescence images are shown. (F) Quantification of the relative pSrc intensity at focal
adhesions. n = 5. Error bars, s.e.m. p<0.01 (*) and p<0.05 (#). (G) Focal adhesions from SCC FAK-WT, FAK P875A/P881A (AA) and FAK -/- cells were
crosslinked and isolated for western blot analysis with the indicated antibodies. Paxillin and Talin served as markers for focal adhesions and Lamin A/C
was used as a nuclear marker. Hsp90 and GAPDH represented cytosolic markers. WCL, whole cell lysate; FA, focal adhesions. The purity of the isolated
focal adhesions was determined by the absence of nuclear proteins like Lamin A/C and cytosolic markers like Hsp90 and GAPDH. There was less active
Src at focal adhesions in the FAK-deficient SCC cells due to Src’s internalisation to autophagic structures. Additionally, increased pPaxillin Y118 and
Talin levels could be detected in the FAK Ambra1-binding mutant compared to SCC FAK-WT and FAK -/- cells. No changes in Ambra1 levels at focal
adhesions could be detected. (H) The relative ratios of pFAK/FAK, pSrc/Src and Ambra1 at focal adhesions were calculated using densitometry. n = 3.
Error bars, s.d. p<0.01 (*) and p<0.05 (#).
DOI: 10.7554/eLife.23172.015
The following source data and figure supplements are available for figure 5:
Source data 1. Relative mean values of adhesion, pSrc intensity at focal adhesions and relative ratios at focal adhesions.
DOI: 10.7554/eLife.23172.016
Figure supplement 1. FAK Ambra1-binding mutant promotes adhesion and invasion.
DOI: 10.7554/eLife.23172.017
Figure supplement 2. FAK Ambra1-binding mutant promotes adhesion and invasion.
DOI: 10.7554/eLife.23172.018
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Figure 6. Ambra1 binding-impaired mutant FAK increases invasion and 3D proliferation, which is rescued by
reducing Dynactin 1 or IFITM3 expression levels. (A) Invasion assay: SCC FAK-WT, FAK P875A/P881A (AA) and
FAK -/- cells were seeded on growth factor-reduced Matrigel in serum-free conditions. After 72 hr, invasion
towards a serum gradient was visualised by staining the cells with calcein. n = 8. Error bars, s.e.m. p0.01. (B)
Representative images of the invasion assay. (C, D) 3D proliferation assay: SCC FAK-WT, FAK P875A/P881A and
FAK -/- cells were resuspended in methylcellulose solution in growth medium on a layer of agarose. After nine
days, images were taken from 6–10 random fields and colonies were counted. (C) Quantification of the 3D
proliferation assay. n = 3. Error bars, s.d. p<0.01. (D) Representative images of the 3D proliferation assay. (E–G)
Invasion assay: SCC FAK-WT, FAK P875A/P881A and FAK -/- cells transiently transfected with Dctn1 siRNA were
seeded on growth factor-reduced Matrigel in serum-free conditions. After 72 hr, invasion towards a serum
gradient was visualised by staining the cells with calcein. (E) Representative images of the invasion assay. (F)
Quantification of the invasion assay. n = 6. Error bars, s.e.m. p0.01. (G) Quantification of the invasion assay with
cells transiently transfected with IFITM3 siRNA. n = 6. Error bars, s.e.m. p0.01 (*) and p<0.05 (#).
DOI: 10.7554/eLife.23172.019
Figure 6 continued on next page
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The FAK-Ambra1 complex controls localisation of active adhesion
components
Expression of a mutant FAK protein (in otherwise FAK-deficient cancer cells) that was hugely
impaired in its ability to bind Ambra1 (FAK P875A/P881A), demonstrated the importance of the
complex between FAK and Ambra1 in promoting the removal of phosphorylated components from
focal adhesions, including active pSrc and pFAK. This Ambra1 binding-impaired mutant FAK protein
caused increased steady-state levels of active pSrc and pFAK at focal adhesions, and enhanced
adhesion, proliferation in 3D and chemotactic invasive migration, without affecting Src/FAK binding.
Enhanced invasion was reversed by knockdown of the Ambra1-binding trafficking proteins Dynactin
1 and IFITM3, demonstrating that these Ambra1-scaffolded proteins are involved in the dynamic
regulation of active pSrc and pFAK, presumably by trafficking them to and from focal adhesions.
Indeed, we found that FAK-driven invasion in the SCC cells was hugely dependent on IFITM3, imply-
ing that its crucial role at the heart of trafficking protein networks linking Ambra1, FAK and active
Src is vital to Src/FAK-mediated invasion. One caveat of interpreting the data with the FAK P875A/
P881A mutant protein is that this mutant is also impaired in binding p130Cas, although to a much
Figure 6 continued
The following source data is available for figure 6:
Source data 1. Mean values of invasion and number of colonies.
DOI: 10.7554/eLife.23172.020
Figure 7. Model for Ambra1’s role in pSrc trafficking and cancer cell phenotypes. In mouse SCC cells, Ambra1 is
localised at autophagosomes and focal adhesions. (A) In FAK-WT expressing (‘normal’) SCC cells, Ambra1 binds
to FAK and Src, regulating Src/FAK-mediated cancer processes like adhesion, invasion, polarisation and 3D
proliferation. (B) In FAK -/- SCC cells, Ambra1 regulates the trafficking of active Src from focal adhesions to
autophagosomes. Dynactin 1 (Dctn1) and IFITM3 are involved in this Ambra1-regulated trafficking process. (C) In
cells expressing the FAK P875A/P881A mutant, Ambra1 binds to a lesser extent to FAK, but still to Src. This
impaired FAK–Ambra1 interaction results in increased active Src levels at focal adhesions, resulting in enhanced
adhesion, invasion, polarisation and 3D proliferation. Most likely this is due to perturbed trafficking of focal
adhesion components, as knockdown of proteins involved in trafficking processes, like Dynactin 1 and IFITM3,
rescues the phenotypes in FAK P875A/P881A expressing SCC cells.
DOI: 10.7554/eLife.23172.021
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lesser extent than Ambra1; importantly though, and in contrast to knockdown of Ambra1, knock-
down of p130Cas did not significantly affect invasion (not shown).
In summary, we have identified a novel role for Ambra1 as part of an intracellular trafficking net-
work of proteins that control the steady-state levels, and dynamics, of active Src and FAK at focal
adhesions. Ambra1 scaffolds proteins such as Dynactin 1 and IFITM3 – and here, for the first time,
we link these to the spatial control of active Src and FAK, regulating their steady-state levels at focal
adhesions and the autophagic targeting of active Src when FAK is absent. As a result, Ambra1 and
its interacting partners control cancer cell adhesion, polarisation, proliferation in 3D and chemotactic
invasion. Deregulation of these trafficking components of focal adhesion complexes inhibits Src/
FAK-dependent biological processes in cancer cells. Our work demonstrates the importance of tight
dynamic control of trafficking of active Src, in particular, to and from focal adhesions.
Materials and methods
Antibodies, inhibitors and DNA constructs
Antibodies used were as follows: anti-Paxillin (RRID:AB_647289), anti-GM130 (RRID:AB_398141),
anti-p130Cas (RRID:AB_397667) and anti-RACK1 (RRID:AB_397577) antibodies (BD Transduction
Laboratories, New Jersey, USA), anti-IFITM3 (RRID:AB_2122095) (Abcam, Cambridge, UK), anti-
CoxIV (RRID:AB_10694213), anti-FAK (RRID:AB_10694068), anti-pFAK Y397 (RRID:AB_2173659),
anti-pPaxillin Y118 (RRID:AB_2174466), anti-Rab7 (RRID:AB_1904103), anti-pSrc Y416 (RRID:AB_
331697), anti-Src (clone 36D10) (RRID:AB_10693939), anti-LC3B (RRID:AB_2137707) and anti-
GAPDH (RRID:AB_10622025) (Cell Signaling Technologies, Danvers, MA, USA), and anti-Dctn1
(RRID:AB_10842517), anti-Ambra1 (RRID:AB_2636939) and anti-pSrc Y416 (RRID:AB_309898) anti-
bodies and anti-FAK (clone 4.47)-conjugated agarose antibody (RRID:AB_310789) (Millipore, Biller-
ica, MA, USA). LC3B antibody was from MBL (RRID:AB_1279144) (MBL International, Woburn, MA,
USA). TRITC-phalloidin was purchased from Life Technologies (RRID:AB_2572408) (Paisley, UK).
Anti-rabbit (RRID:AB_2099233) or mouse (RRID:AB_330924) peroxidase-conjugated secondary anti-
bodies were purchased from Cell Signaling Technologies. Dasatinib was obtained from Bristol Myers
Squibb (Princeton, NJ, USA) and PF562271 from Pfizer (Groton, CT, USA).
Generation of FAK mutant constructs
FAK mutants were generated by site-directed mutagenesis using PFU Ultra Hotstart DNA polymer-
ase (Stratagene, Amsterdam, The Netherlands) and the following primers (mutated base pairs are
underlined): P875A (forward 5’ – GATCATGCCGCTCCAGCAAAGAAGCCCCCT – 3’, reverse 5’ –
GCGAGGGGGCTTCTTTGCTGGAGCGGCATG – 3’) and P881A (forward 5’ – CAAAGAAGCCCCC
TCGCGCTGGAGCCCCCC – 3’, reverse 5’ – CAAGTGGGGGGCTCCAGCGCGAGGGGGCTT – 3’).
After DpnI digestion for 1 hr at 37˚C, chemically competent TOP10 bacteria were transformed.
Cell culture and transfection
FAK-deficient SCC cell lines were generated, authenticated and characterised as described previ-
ously (Serrels et al., 2012, 2010). SCCs were maintained in Glasgow MEM containing 10% FCS, 2
mM L-glutamine, non-essential amino acids, sodium pyruvate and MEM vitamins at 37˚C, 5% CO2.
SCC FAK-WT cells were maintained in 1 mg/ml hygromycin B. Ambra1 +/+ and -/- RasV12/E1A-
transformed MEFs were a generous gift from Guillermo Velasco (Cianfanelli et al., 2015). MEFs
were cultured in DMEM supplemented with 10% FCS and 2 mM L-glutamine at 37˚C, 5% CO2. Fol-
lowing thawing cells were used for no longer than three months. Original cells were pathogen tested
using the ImpactIII test (Idexx Bioresearch, Westbrook, ME, USA) and were negative for all patho-
gens tested. All cell lines were routinely tested negative for mycoplasma contamination.
siRNA
Ambra1 siRNA pool (cat. no. M-059556–01), individual Ambra1 siRNAs (cat. no. D-059556–01, 5’ –
GAAGAAUGCUGUACGAAUC – 3’; D-059556–04, 5’ – CAACGUGCCCUCCUGCAAU – 3’), Dctn1
siRNA pool (cat. no. M-044821–01), IFITM3 siRNA pool (cat. no. M-056653–01) or scrambled siRNA
(cat. no. D-001206-13-20) were purchased from Dharmacon (Loughborough, UK). FAK-WT or FAK -/-
SCC cells were transiently transfected using HiPerFect (Qiagen, Manchester, UK) according to the
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manufacturer’s protocol, with a final concentration of 100 nM siRNA, respectively. Cells were ana-
lysed at 48–72 hr post transfection.
Mapping of the Ambra1 binding site in FAK
The Ambra1 binding site in FAK was identified using peptide arrays as published previously
(Serrels et al., 2010, 2007). Briefly, overlapping 25-mer peptides of FAK were spotted onto nitro-
cellulose and incubated with recombinant Ambra1 (Origene, Herford, Germany). After extensive
washes, the array was incubated with anti-Ambra1 antibody and then subjected to western blotting.
For the identification of core amino acids, overlapping 25-mer peptides with one amino acid
mutated at a time were used.
Immunoblotting, immunoprecipitation and mass spectrometry
Cells were washed twice in ice-cold PBS and then lysed in RIPA buffer (50 mM Tris-HCl, pH 8.0, 150
mM NaCl, 1% Triton X-100, 0.1% SDS and 0.5% sodium deoxycholate) supplemented with PhosStop
and Complete Ultra Protease Inhibitor tablets (Roche, Welwyn Garden City, UK). Lysates were
cleared by centrifugation at 10000 rpm for 15 min and analyzed by western blotting. Protein concen-
tration was calculated using a BCA protein assay kit (Thermo Scientific, Loughborough, UK). For
immunoprecipitation, 1 mg cell lysates were incubated with 2 mg of unconjugated or 10 ml of aga-
rose-conjugated antibodies at 4˚C overnight with agitation. Unconjugated antibody samples were
incubated with 10 ml of Protein A or Protein G agarose for 1 hr at 4˚C. Beads were washed three
times in lysis buffer and once in 0.6 M LiCl, resuspended in 20 ml 2x sample buffer (130 mM Tris-HCl,
pH 6.8, 20% glycerol, 5% SDS, 8% b-mercaptoethanol, bromophenol blue) and heated for 5 min at
95˚C. Samples were then subjected to SDS-PAGE analysis using the Bio-Rad TGX pre-cast gel sys-
tem. Proteins were immunoblotted using the Bio-Rad Trans-blot Turbo transfer system, blocked in
5% BSA in TBST (TBS supplemented with 1% Tween-20), and incubated with primary antibody over-
night at 4˚C. Blots were washed three times in TBST, incubated with peroxidase-conjugated second-
ary antibody for 45 min at room temperature, washed as before, developed using Clarity Western
ECL Substrate (Bio-Rad, Hemel Hempstead, UK) and imaged using a Bio-Rad ChemiDoc MP Imaging
System (Bio-Rad, Hemel Hempstead, UK).
For mass spectrometry, SCC FAK-WT and -/- cells were lysed in RIPA buffer. For the immunopre-
cipitations, 2 mg cell lysates (samples in triplicates) were incubated with 2 mg of unconjugated anti-
bodies (anti-Ambra1, anti-pSrc Y416 and rabbit-anti-IgG) or 10 ml of agarose-conjugated antibodies
(FAK–agarose) at 4˚C overnight with agitation. Unconjugated antibody samples were incubated with
20 ml of Protein A agarose for 1 hr at 4˚C. Beads were washed twice in lysis buffer and twice in PBS.
Protein complexes were subjected to on-bead proteolytic digestion, followed by desalting and liquid
chromatography–tandem mass spectrometry as reported previously (Turriziani et al., 2014). The
mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via
the PRIDE partner repository (Vizcaı´no et al., 2016) with the dataset identifier PXD006002. Traffick-
ing proteins were filtered from the total datasets and the interaction network analysis was performed
using Cytoscape (RRID:SCR_003032).
Immunofluorescence microscopy and image analysis
Cells were grown on glass coverslips for 24 hr and washed once in TBS prior to fixation (3.7% formal-
dehyde, 100 mM PIPES, pH 6.8, 10 mM EGTA, 1 mM MgCl2 and 0.2% Triton X-100) for 10 min. Cells
were subsequently washed twice in TBStx (TBS supplemented with 0.1% Triton X-100) and blocked
in TBStx block (TBStx supplemented with 3% BSA). Primary antibodies were incubated in TBStx
block overnight at 4˚C, followed by three 5 min washes in TBStx, incubated with Alexa Fluor-labelled
secondary antibodies diluted 1:200 in TBStx block (Life Technologies, Paisley, UK) and washed as
before prior to being mounted in Vectashield mounting medium containing DAPI (Vector Labs,
Peterborough, UK). Cells were imaged using a FV1000 confocal microscope (Olympus, Southend-
on-Sea, UK).
For the Total Internal Reflection Fluorescence (TIRF) microscopy an inverted IX81 microscope
(Olympus, Southend-on-Sea, UK) with a 150  1.45 NA UAPON TIRF objective using 491 and 561
excitation lines was used. Colocalisation was analyzed using the ImageJ plugin JaCoP (Bolte and
Cordelie`res, 2006).
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The intensity of pSrc or Paxillin at focal adhesions from three independent experiments (five cells
per experiment; at least 10 focal adhesions per cells) was measured using ImageJ (RRID:SCR_
003070).
Focal adhesion isolation
Focal adhesion isolation was performed following the protocol described in ref. (Kuo et al., 2012).
Briefly, cells were rinsed with PBS and incubated with TEA buffer (0.2 M triethanolamine, pH 8.0) for
5 min. To apply hydrodynamic force, the cells were rinsed with PBS for 10 s using a Waterpik dental
flosser set at 2 (Waterpik, Reigate, UK). After another wash with PBS, the remaining attached focal
adhesions were fixed for immunofluorescence analysis.
For western blot analysis, focal adhesions were crosslinked with 3 mM dimethyl 3,3’-dithiobispro-
pionimidate (DTBP; Thermo Scientific, Loughborough, UK) for 30 min at room temperature and then
quenched with 20 mM Tris-HCl, pH 8.0, for 5 min at room temperature. After another wash with 20
mM Tris-HCl, pH 8.0, cells were rinsed with ice-cold PBS, and 5 ml of focal adhesion extraction
buffer (0.5% Triton X-100, 20 mM NH4OH in PBS) was added to the cells for 5 min. Cells were rinsed
with PBS for 10 s using a Waterpik dental flosser set at 2, and the remaining attached focal adhe-
sions were lysed in 2x sample buffer. Western blot bands were analysed by densitometry.
Cell polarisation assays
Cell polarisation assessing the orientation of the Golgi apparatus in wounded cell monolayers was
examined as described in (Serrels et al., 2010). Briefly, 3  106 cells were plated on fibronectin-
coated coverslips in 12-well plates for 3 hr. The cell monolayer was wounded with a pipette tip, incu-
bated in full SCC growth medium for 1.5 hr and then fixed and stained with anti-GM130 antibody.
Invasion assays
Invasion was analysed as described in (Serrels et al., 2010). Briefly, growth factor-reduced Matrigel
(BD Biosciences, Oxford, UK) was diluted 1:1 in cold PBS and allowed to set at 37˚C in transwells. 2
 104 cells were seeded onto the underside of the transwell. After 4 hr, the transwells were washed
in PBS and placed into serum-free SCC growth medium. Full growth medium containing 10% FCS
was added on top of the Matrigel. After 72 hr, cell invasion was assessed by staining with 5 mM cal-
cein (Life Technologies, Paisley, UK) for 1 hr. Horizontal z sections through the Matrigel were
acquired at 10 mm intervals with an Olympus FV1000 confocal microscope. The images were evalu-
ated using ImageJ software.
Adhesion assay
Cells were washed twice in PBS, resuspended in PBS and rotated for 45 min at 4˚C. After that, 8000
cells/well were plated in serum-free medium on fibronectin-coated 96-well plates or on plastic at
37˚C. Cells were fixed after 20 min, 1, 2 and 6 hr with 25% trichloracetic acid (TCA) and stored over-
night at 4˚C. Plates were washed five times with H2O and dried at 37˚C. The fixed cells were stained
with sulforhodamine B (SRB) (0.4% SRB in 1% acetic acid) for 30 min, washed five times with 1% ace-
tic acid and dried at 37˚C. The SRB was dissolved in 10 mM Tris, pH 10.5, for 2 hr at room tempera-
ture and the absorbance was read at 540 nm. Samples were normalised to the 6 hr time point and
relative adhesion was calculated by setting the FAK-WT values to 1.
3D proliferation assay
Cells were resuspended in a 1.4% methylcellulose solution in growth medium, plated on a layer of
0.9% agarose and incubated at 37˚C, 5% CO2. After nine days, images were taken from 6–10 ran-
dom fields (10x magnification) and colonies were counted.
Statistical tests
For measuring the intensity of pSrc Y416 staining at focal adhesions (immunofluorescence), n = 5 (5
cells per experiment). For the invasion assay, the experiment was repeated with the following times:
siAmbra1, n = 5; FAK P875A/P881A mutant, n = 8; siDctn1; n = 6 and siIFITM3, n = 6. All other
experiments shown, n = 3. Quantification of internalised active Src was carried out by counting 100
cells and calculating the percentage. Error bars for the graphs showing the intensity of pSrc Y416
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staining at focal adhesions and the invasion assays represent s.e.m. Error bars for all other experi-
ments show s.d. Student’s t-test was carried out to calculate the statistical significance.
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